Details for New Drug Application (NDA): 213316
✉ Email this page to a colleague
The generic ingredient in TETRABENAZINE is tetrabenazine. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the tetrabenazine profile page.
Summary for 213316
Tradename: | TETRABENAZINE |
Applicant: | Slate Run Pharma |
Ingredient: | tetrabenazine |
Patents: | 0 |
Pharmacology for NDA: 213316
Mechanism of Action | Vesicular Monoamine Transporter 2 Inhibitors |
Medical Subject Heading (MeSH) Categories for 213316
Suppliers and Packaging for NDA: 213316
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TETRABENAZINE | tetrabenazine | TABLET;ORAL | 213316 | ANDA | Slate Run Pharmaceuticals, LLC | 70436-101 | 70436-101-09 | 112 TABLET in 1 BOTTLE (70436-101-09) |
TETRABENAZINE | tetrabenazine | TABLET;ORAL | 213316 | ANDA | Slate Run Pharmaceuticals, LLC | 70436-102 | 70436-102-09 | 112 TABLET in 1 BOTTLE (70436-102-09) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG | ||||
Approval Date: | Jan 22, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Jan 22, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription